This nationwide retrospective study provides a comprehensive overview of first-line treatment strategies for primary mediastinal B-cell lymphoma (PMBCL) across Italy, reflecting real-world clinical practice.
The analysis underscores significant heterogeneity in treatment regimens, reflecting the absence of a universally accepted standard approach.
Clinical outcomes and treatment tolerability data offer insight into optimizing management strategies and guiding selection of first-line therapies in routine care.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
